XML 59 R44.htm IDEA: XBRL DOCUMENT v3.10.0.1
SUMMARY OF SIGNIFICANT ACCOUNTING POLICIES – Revenue Recognition, Balances Reported with and without Adoption of ASC 606 (Details) - USD ($)
$ in Thousands
3 Months Ended 9 Months Ended
Sep. 30, 2018
Sep. 30, 2017
Sep. 30, 2018
Sep. 30, 2017
Jan. 01, 2018
Dec. 31, 2017
Consolidated Statements of Income            
Net sales $ 665,775 $ 624,326 $ 2,079,733 $ 1,843,388    
Costs and Expenses            
Cost of sales 435,379 407,781 1,355,445 1,192,129    
Provision for income taxes 11,920 15,989 52,966 48,043    
Net income 39,022 53,529 154,091 170,523    
Assets            
Accounts and note receivable 580,450   580,450     $ 510,426
Inventories 394,264   394,264   $ 322,579 337,216
Prepaid and other 118,613   118,613   123,775 109,791
Liabilities            
Accounts payable and accrued liabilities 524,528   524,528   455,873 461,579
Deferred income taxes 48,857   48,857   22,287 20,995
Deferred and other non-current liabilities 24,837   24,837   6,432 5,608
Stockholders' Equity            
Retained earnings 1,345,851   1,345,851   1,304,084 $ 1,301,147
Beauty + Home            
Consolidated Statements of Income            
Net sales 341,760 333,748 1,088,469 978,313    
Pharma            
Consolidated Statements of Income            
Net sales 227,515 199,547 698,851 598,161    
Food + Beverage            
Consolidated Statements of Income            
Net sales 96,500 $ 91,031 292,413 $ 266,914    
Balances Without Adoption of ASC 606 | Accounting Standards Update 2014-09            
Costs and Expenses            
Cost of sales 434,601   1,354,844      
Provision for income taxes 11,866   53,138      
Net income 38,870   154,445      
Assets            
Inventories 409,502   409,502      
Prepaid and other 102,767   102,767      
Liabilities            
Accounts payable and accrued liabilities 528,081   528,081      
Deferred income taxes 47,737   47,737      
Deferred and other non-current liabilities 24,379   24,379      
Stockholders' Equity            
Retained earnings 1,343,268   1,343,268      
Balances Without Adoption of ASC 606 | Accounting Standards Update 2014-09 | Beauty + Home            
Consolidated Statements of Income            
Net sales 340,787   1,087,922      
Balances Without Adoption of ASC 606 | Accounting Standards Update 2014-09 | Pharma            
Consolidated Statements of Income            
Net sales 227,526   699,299      
Balances Without Adoption of ASC 606 | Accounting Standards Update 2014-09 | Food + Beverage            
Consolidated Statements of Income            
Net sales 96,478   292,437      
Adjustment/Effect of Change | Accounting Standards Update 2014-09            
Costs and Expenses            
Cost of sales 778   601      
Provision for income taxes 54   (172)      
Net income 152   (354)      
Assets            
Inventories (15,238)   (15,238)   (14,637)  
Prepaid and other 15,846   15,846   13,984  
Liabilities            
Accounts payable and accrued liabilities (3,553)   (3,553)   (5,706)  
Deferred income taxes 1,120   1,120   1,292  
Deferred and other non-current liabilities 458   458   824  
Stockholders' Equity            
Retained earnings 2,583   2,583   $ 2,937  
Adjustment/Effect of Change | Accounting Standards Update 2014-09 | Beauty + Home            
Consolidated Statements of Income            
Net sales 973   547      
Adjustment/Effect of Change | Accounting Standards Update 2014-09 | Pharma            
Consolidated Statements of Income            
Net sales (11)   (448)      
Adjustment/Effect of Change | Accounting Standards Update 2014-09 | Food + Beverage            
Consolidated Statements of Income            
Net sales $ 22   $ (24)